Evidence map›Paper›PMID 29298854›Full record

ArticleNeurology2018

Racial disparities in refusal of stroke thrombolysis in Chicago.

Scott J Mendelson, Neelum T Aggarwal, Christopher Richards, Kathleen O'Neill, Jane L Holl, Shyam Prabhakaran

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06094478 (Implementation of a Stroke Protocol for Emergency Evaluation and Disposition), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06094478 narecruitingnot on this mapstarted 2024, after this paper: background citation

Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

TypeinterventionalSponsorUniversity of ChicagoRan2024 to 2028Enrolled900ConditionsStroke, Acute, Ischemic Stroke, Acute, Hemorrhagic StrokeArmsHI-SPEED Protocol
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Black Americans have worse stroke outcome compared with non-Hispanic whites.Journal of the National Medical Association · 2023
    Article
  4. Racial and Ethnic Disparities in Stroke Reperfusion Therapy in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Thrombolytic Refusal Over Telestroke.Neurology. Clinical practice · 2021
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Scott J MendelsonFrom the Department of Neurology (S.J.M., S.P.), Department of Emergency Medicine (C.R.), and Center for Healthcare Studies (J.L.H.), Northwestern University Feinberg School of Medicine; Department of Neurologic Sciences and the Rush Alzheimer's Disease Center (N.T.A.), Rush University Medical Center; and American Heart Association (K.O.), Midwest Affiliate, Chicago, IL. scott.mendelson@northwestern.edu.
Neelum T AggarwalFrom the Department of Neurology (S.J.M., S.P.), Department of Emergency Medicine (C.R.), and Center for Healthcare Studies (J.L.H.), Northwestern University Feinberg School of Medicine; Department of Neurologic Sciences and the Rush Alzheimer's Disease Center (N.T.A.), Rush University Medical Center; and American Heart Association (K.O.), Midwest Affiliate, Chicago, IL.
Christopher RichardsFrom the Department of Neurology (S.J.M., S.P.), Department of Emergency Medicine (C.R.), and Center for Healthcare Studies (J.L.H.), Northwestern University Feinberg School of Medicine; Department of Neurologic Sciences and the Rush Alzheimer's Disease Center (N.T.A.), Rush University Medical Center; and American Heart Association (K.O.), Midwest Affiliate, Chicago, IL.
Kathleen O'NeillFrom the Department of Neurology (S.J.M., S.P.), Department of Emergency Medicine (C.R.), and Center for Healthcare Studies (J.L.H.), Northwestern University Feinberg School of Medicine; Department of Neurologic Sciences and the Rush Alzheimer's Disease Center (N.T.A.), Rush University Medical Center; and American Heart Association (K.O.), Midwest Affiliate, Chicago, IL.
Jane L HollFrom the Department of Neurology (S.J.M., S.P.), Department of Emergency Medicine (C.R.), and Center for Healthcare Studies (J.L.H.), Northwestern University Feinberg School of Medicine; Department of Neurologic Sciences and the Rush Alzheimer's Disease Center (N.T.A.), Rush University Medical Center; and American Heart Association (K.O.), Midwest Affiliate, Chicago, IL.
Shyam PrabhakaranFrom the Department of Neurology (S.J.M., S.P.), Department of Emergency Medicine (C.R.), and Center for Healthcare Studies (J.L.H.), Northwestern University Feinberg School of Medicine; Department of Neurologic Sciences and the Rush Alzheimer's Disease Center (N.T.A.), Rush University Medical Center; and American Heart Association (K.O.), Midwest Affiliate, Chicago, IL.
Rush University Medical Center · US

Funding

Stroke Trials Network - Regional Coordinating Stroke CentersU10NS086608 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PRABHAKARAN, SHYAM · 2013 to 2017
$1.8M
NINDS NIH HHS U10 NS086608
6 · The paper itself

Abstract

objectiveTo evaluate race differences in tissue plasminogen activator (tPA) refusal among eligible patients with acute ischemic stroke (AIS) in Chicago.

methodsUsing the Get With The Guidelines-Stroke registry data from 15 primary stroke centers between January 2013 and June 2015, we performed a retrospective analysis of patients with AIS presenting to the emergency department within 4.5 hours from symptom onset. Patient or proxy refusal was captured as a reason for nonadministration of tPA to eligible patients in the registry. We assessed whether tPA refusal differed by race using logistic regression.

resultsAmong 704 tPA-eligible patients with AIS, tPA was administered to 86.2% (black race, 82.5% vs nonblack race, 89.5%;

conclusionsAmong tPA-eligible patients with AIS in Chicago, over 7% refused tPA. Refusal was more common in black patients and accounted for the apparent lower rates of tPA use in black vs nonblack patients. Further research is needed to understand barriers to consent and overcome race-ethnic disparities in tPA treatment for AIS.

Indexed as

StrokeAgedBlack or African AmericanBlack PeopleChicagoEthnicityFemaleFibrinolytic AgentsHumansMaleMiddle AgedMultivariate AnalysisRegistriesRetrospective StudiesTissue Plasminogen ActivatorTreatment OutcomeFibrinolytic AgentsTissue Plasminogen Activator

Identifiers

PMID29298854
PMCPMC10681073
OpenAlexW2781594979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.